Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Gupta, SK; Post, FA; Arribas, JR; Eron, JJ; Wohl, DA; Clarke, AE; Sax, PE; Stellbrink, HJ; Esser, S; Pozniak, AL; Podzamczer, D; Waters, L; Orkin, C; Rockstroh, JK; Mudrikova, T; Negredo, E; Elion, RA; Guo, S; Zhong, LJ; Carter, C; Martin, H; Brainar

Gupta, SK (reprint author), Indiana Univ Sch Med, Div Infect Dis, Dept Med, Emerson Hall,Suite 421,545 Barnhill Dr, Indianapolis, IN 46202 USA.

AIDS, 2019; 33 (9): 1455

Abstract

Objective: Compared with tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF) has been associated with improvement in markers of renal dys......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索